Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Bioinformatics and Biotechnology

Date Submitted: Jul 5, 2022
Date Accepted: Nov 5, 2022

The final, peer-reviewed published version of this preprint can be found here:

Monitoring Risk Factors and Improving Adherence to Therapy in Patients With Chronic Kidney Disease (Smit-CKD Project): Pilot Observational Study

Vilasi A, Panuccio V, Morante S, Villa A, Versace MC, Mezzatesta S, Mercuri S, Inguanta R, Aiello G, Cutrupi D, Puglisi R, Capria S, Li Vigni M, Tripepi G, Torino C

Monitoring Risk Factors and Improving Adherence to Therapy in Patients With Chronic Kidney Disease (Smit-CKD Project): Pilot Observational Study

JMIR Bioinform Biotech 2022;3(1):e36766

DOI: 10.2196/36766

PMCID: 11135230

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Monitoring risk factors and improving adherence to therapy in CKD patients. The SMIT-CKD project.

  • Antonio Vilasi; 
  • Vincenzo Panuccio; 
  • Salvatore Morante; 
  • Antonino Villa; 
  • Maria Carmela Versace; 
  • Sabrina Mezzatesta; 
  • Sergio Mercuri; 
  • Rosalinda Inguanta; 
  • Giuseppe Aiello; 
  • Demetrio Cutrupi; 
  • Rossella Puglisi; 
  • Salvatore Capria; 
  • Maurizio Li Vigni; 
  • Giovanni Tripepi; 
  • Claudia Torino

ABSTRACT

Background:

Chronic Kidney Disease is a major public health issue, with about 13% of the general adult population and 30% of the elderly affected. Patients in the last stage of this disease have an almost uniquely high risk of death and cardiovascular events, with reduced adherence to therapy representing an additional risk factor for cardiovascular morbidity and mortality. Considering the wide spreading of mobile phones, a mobile app could educate patients in self-monitoring cardio-renal risk factors.

Objective:

To develop an integrated system to educate patients in self-monitoring cardio-renal risk factors.

Methods:

We developed an integrated system made by a server and an app, with the aim of improving self-monitoring of cardiovascular and renal risk factors and of improving adherence to therapy.

Results:

The SMIT-CKD APP allows the monitoring of cardio-renal risk factors and their transmission to the referring GP. Special reminders help drug administration. Via the SMIT-CKD Server, GPs can monitor the clinical status of their patients and adherence to therapy. During the test, 73% of subjects entered all the required data regularly and sent feedbacks of drug intake. Looking at the evaluation questionnaires, both the app and the server counterpart were well accepted by the users.

Conclusions:

Our study demonstrated that a simple Mobile APP, created to self-monitor modifiable cardio-renal risk factor and adherence to therapy, is well tolerated by patients affected by Chronic Kidney Disease. Further studies are required to clarify if the use of this integrated system will have long-term effects on therapy adherence, and if self-monitoring of risk factors will improve clinical outcomes in this population. Clinical Trial: NA


 Citation

Please cite as:

Vilasi A, Panuccio V, Morante S, Villa A, Versace MC, Mezzatesta S, Mercuri S, Inguanta R, Aiello G, Cutrupi D, Puglisi R, Capria S, Li Vigni M, Tripepi G, Torino C

Monitoring Risk Factors and Improving Adherence to Therapy in Patients With Chronic Kidney Disease (Smit-CKD Project): Pilot Observational Study

JMIR Bioinform Biotech 2022;3(1):e36766

DOI: 10.2196/36766

PMCID: 11135230

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.